MICB and cancer: It is of importance that, in contrast to the effects on cancer cells, MICA and MICB, in terms both of protein surface and mRNA levels, on NHA were not affected by SR141716 treatment (Fig. 2B), suggesting that SR141716 was able to specifically upregulate “danger signals” for NK cells in malignant but not in healthy cells.